Invention Grant
- Patent Title: Multiepitope vaccine for Her2/neu-associated cancers
- Patent Title (中): 用于Her2 / neu相关癌症的多表位疫苗
-
Application No.: US13389419Application Date: 2010-08-18
-
Publication No.: US08852604B2Publication Date: 2014-10-07
- Inventor: Andreas Kammer , Mario Amacker , Rinaldo Zurbriggen
- Applicant: Andreas Kammer , Mario Amacker , Rinaldo Zurbriggen
- Applicant Address: CH Ittigen
- Assignee: Pevion Biotech AG
- Current Assignee: Pevion Biotech AG
- Current Assignee Address: CH Ittigen
- Agency: Saul Ewing, LLP
- Agent Kathryn Doyle
- Priority: EP09010627 20090818
- International Application: PCT/EP2010/005071 WO 20100818
- International Announcement: WO2011/020604 WO 20110224
- Main IPC: C07K19/00
- IPC: C07K19/00 ; C07K14/71 ; A61K39/00
Abstract:
The present invention includes fusion peptides comprising fragments of the cancer-related protein Her2/neu, methods of preparing such fusion peptides, virosomes comprising such fusion peptides, and uses of such fusion peptides or virosomes for the prevention, treatment or amelioration of a cancer characterized by expression or over-expression of the Her2/neu protein.
Public/Granted literature
- US20120195962A1 Multiepitope Vaccine for Her2/Neu-Associated Cancers Public/Granted day:2012-08-02
Information query
